NIVI - A $260m Vaccine R&D Initiative That Benefits From Wegovy Windfall

The Novo Nordisk Foundation is funding a project to develop vaccines that generate a local immune response at the site of infection – in the case of respiratory diseases in the airways – which could help prevent even mild infections, block transmission and generate long-term immunity.